Artax Biopharma
Biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$104—156m (Dealroom.co estimates May 2022.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $1.3m | Seed | |
| N/A | $2.0m | Seed | |
| N/A | $2.0m | Series A | |
$10.0m | Series B | ||
| N/A | N/A | Early VC | |
| N/A | $750k | Early VC | |
N/A | Series B | ||
| N/A | $12.7m | Late VC | |
* | $26.0m | Late VC | |
* | $8.0m | Convertible | |
| Total Funding | $62.8m | ||
Related Content
Recent News about Artax Biopharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.